Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current DebtOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Harmony Biosciences Holdings (HRMY) Finished Goods: 2023-2024

Historic Finished Goods for Harmony Biosciences Holdings (HRMY) over the last 1 years, with Dec 2024 value amounting to $2.8 million.

  • Harmony Biosciences Holdings' Finished Goods rose 21.11% to $2.8 million in Q4 2024 from the same period last year, while for Dec 2024 it was $2.8 million, marking a year-over-year increase of 21.11%. This contributed to the annual value of $2.8 million for FY2024, which is 21.11% up from last year.
  • According to the latest figures from Q4 2024, Harmony Biosciences Holdings' Finished Goods is $2.8 million, which was down 17.04% from $3.3 million recorded in Q3 2024.
  • In the past 5 years, Harmony Biosciences Holdings' Finished Goods registered a high of $3.3 million during Q3 2024, and its lowest value of $2.3 million during Q4 2023.
  • For the 2-year period, Harmony Biosciences Holdings' Finished Goods averaged around $2.8 million, with its median value being $2.8 million (2024).
  • Data for Harmony Biosciences Holdings' Finished Goods shows a peak YoY climbed of 21.11% (in 2024) over the last 5 years.
  • Quarterly analysis of 2 years shows Harmony Biosciences Holdings' Finished Goods stood at $2.3 million in 2023, then rose by 21.11% to $2.8 million in 2024.
  • Its last three reported values are $2.8 million in Q4 2024, $3.3 million for Q3 2024, and $2.8 million during Q2 2024.